AMP · Ameriprise Financial, Inc. · Stock research

Current Thesis

The leg on offer is operating leverage in a scale advice platform. Q2 2026 (reported 2026-07-23) put adjusted operating EPS at $11.07, +22% YoY, against $10.73 consensus, on revenue of $4.940B (+13%) versus $4.790B expected. Adjusted operating return on equity was 55%, up from 51.5% a year earlier, and AUM/AUA closed the quarter at a record $1.81T, +14%. At $545.84 (2026-07-31) the market pays 13.19x trailing and 11.18x forward earnings for that.

The complication is where the growth comes from and where the price sits. Organic gathering is slowing — total client net flows of $3.1B in Q2 versus $4.2B in Q1 2026, with Asset Management still redeeming $6.5B net — while margin, market levels and buyback carry the earnings line. Meanwhile price is roughly 15% above a 50-DMA and 200-DMA that sit essentially on top of each other near $474, and the 52-week high of $553.46 stalls just under the November 2024 peak around $553.79 and below the 2025-01-29 closing high of $571.66. Nothing company-specific resolves this before the Q3 print in late October.

Life-cycle: MATURING. The name is well covered (5 Buy / 8 Hold / 1 Sell as of late July 2026), the earnings engine is still working (+22% EPS, 2026-07-23), and the flow that feeds it is moderating (client net flows $4.2B → $3.1B across Q1 and Q2 2026). There is no evidence of the mainstream-coverage crowding that would date it SATURATED — the forward multiple is 11.18x and price has not reclaimed its January 2025 high.

Bullish and bearish views on Ameriprise Financial, Inc.

The model's bull view on Ameriprise Financial, Inc. (AMP), in brief: Q2 2026 (2026-07-23): adjusted operating EPS $11.07, +22% YoY, beat consensus $10.73; revenue $4.940B vs $4.790B. The bear view: Organic flows are decelerating. Total client net flows $3.1B in Q2 2026 against $4.2B in Q1 2026 — and Q1's $4.2B was itself down 59% from Q1 2025. Wrap flows of $6.9B in Q2 carried Comerica-related terminations and seasonal tax outflows. Asset Management remains in net… Both cases follow in full.

Bull Case

• Q2 2026 (2026-07-23): adjusted operating EPS $11.07, +22% YoY, beat consensus $10.73; revenue $4.940B vs $4.790B. Adjusted operating ROE 55% vs 51.5% a year prior.
• AUM/AUA a record $1.81T at 2026-06-30, +14% YoY. Total client assets $1.2T (+15%); wrap assets $732B (+19%).
• Advice & Wealth Management adjusted operating net revenue $3.2B (+16%), pre-tax adjusted operating earnings $939M (+16%), margin 29%.
• Columbia Threadneedle pre-tax adjusted operating earnings $274M (+23%) at a 43% margin — above the company's stated 35–39% target band. 87% of funds above median over ten years; 97 funds at four or five Morningstar stars (2026-07-23).
• Advisor productivity a record $1.2M per advisor, +12% YoY, across a network management sizes at more than 10,000 advisors. On the 2026-07-23 call management attributed the gain to tooling: roughly 6,000 advisors on engagement and meeting automation, with practices running all three tools saving "more than 30 hours per week."
• Contracted asset pipeline. Huntington Bank selected Ameriprise as its retail investment program provider on 2026-02-04 — approximately 260 advisors and $28B of client assets, guided to onboard in Q4 2026. That is larger than the ~$19B Comerica book leaving.
• Capital return: $932M in Q2 2026, equal to 91% of operating earnings, including 1.7M shares repurchased at an average $459. First-half return $1.9B, +25% YoY, 3.3M shares at an average $467. Quarterly dividend raised 6% to $1.70.
• Balance sheet: $2.1B excess capital, $2.8B holding-company liquidity, bank book yielding 4.7% with new purchases at 5.2% (2026-07-23 call).

Bear Case

• Organic flows are decelerating. Total client net flows $3.1B in Q2 2026 against $4.2B in Q1 2026 — and Q1's $4.2B was itself down 59% from Q1 2025. Wrap flows of $6.9B in Q2 carried Comerica-related terminations and seasonal tax outflows.
• Asset Management remains in net redemption: -$6.5B in Q2 2026 (an improvement of 26% YoY, still negative) after -$5.9B in Q1 2026. Earnings growth in that segment came from margin, not from gathering.
• Client cash was $84B at 2026-06-30, down 2% YoY, with $46.6B sitting in third-party money market funds. The spread business reprices with the front end; a 4.7% bank yield is a falling-rate liability.
• Advisor attrition. CFO Walter Berman flagged "higher advisor departures" in an "aggressive recruiting environment" on the 2026-04-23 call; on 2026-07-23 management cited competitor packages with payback periods "as high as eight years." Q2 recruiting added 79 experienced advisors, Q1 added 61 — small numbers against a 10,000-advisor base.
• Cash-sweep litigation is live. Multiple class actions, including one filed in Minnesota federal court, allege Ameriprise paid unreasonably low rates on swept client cash while capturing the spread. Unresolved.
• Sell-side raised targets without changing its mind. Between 2026-07-10 and 2026-07-24: Jefferies Buy PT→$645, Morgan Stanley Underweight PT→$489, Piper Sandler Neutral PT→$518, Evercore ISI In-Line PT→$625, KBW Market Perform PT→$545. All five maintained their existing ratings. The dispersion — $489 to $645 — brackets the current price almost symmetrically.
• The company repurchased at an average $459 in Q2 2026. Shares closed $545.84 on 2026-07-31, roughly 19% above where the buyback was executing.

Setup & Price Structure

• Close $545.84 on 2026-07-31. 52-week range $422.37–$553.46. Market cap $48.25B on 88.40M shares. Beta 1.13.
• 50-DMA approximately $474.03 and 200-DMA approximately $474.45 as of 2026-07-23 — converged and flat, with price roughly 15% above both. That extension is large for a name with this beta and it is the single most crowding-relevant observable on the chart.
• This is not new-high territory in absolute terms. The intraday all-time high is $582.05 (2025-01-30) and the closing all-time high $571.66 (2025-01-29). Current price sits about 4.5% under that close, inside the supply band built between November 2024 and January 2025.
• The 52-week high was quoted at $550.18 on 2026-07-23 and $553.46 on 2026-07-31, so a new 52-week high was set in the post-print week — and it stopped essentially at the November 2024 peak near $553.79. Inference, not measurement: that band is acting as overhead resistance rather than a launch shelf.
• Print-day behaviour was muted. Shares traded around $520 on 2026-07-23 despite the beat; the advance to $545.84 came over the following six sessions.
• roughly a one-third reduction in direct holdings, executed five sessions after the print and within a dollar of the 52-week high. Retail-facing coverage clustered on that sale in the following days (2026-07-29 to 2026-07-30). Zacks moved the name to Strong Buy on 2026-07-29.

Catalyst Calendar (next 30 days)

• 2026-08-03 — ex-dividend, $1.70 per share, payable 2026-08-21. Mechanical, roughly 0.3% of price. It confirms the 6% raise declared with Q2 and resolves nothing else.
• ~2026-08-20 (est.) — Jackson Hole symposium. Not company-specific, but the front-end rate path prices the spread on $25.5B of bank assets and $84B of client cash.
• The rest of the window is empty. No company-reported datapoint lands before late September, which makes this an eleven-week catalyst void starting from an extended price.

Beyond 30 days, for context:

• 2026-09-30 (est.) — Comerica conversion completes; management guided approximately $19B of client assets out by the end of Q3 2026.
• ~2026-10-21 (est.) — Q3 2026 results. The first print that shows whether flows re-accelerate with Comerica gone, and whether Huntington is still tracking to Q4.
• ~2026-12-31 (est.) — Huntington onboarding of approximately 260 advisors and $28B of client assets.

What Would Change Our Mind

The structure is the thing to watch. July's advance is the first serious challenge to the January 2025 high in eighteen months, and it stalled within a few dollars of the November 2024 peak. If that rejection holds and the post-print move is given back, the correct reading of the chart flips from base-and-breakout to a lower high inside a long range. A weekly close below $500 would return price to the zone it occupied before 2026-07-23 and end the leg; the 50-DMA and 200-DMA cluster near $474 is the next reference beneath it.

Two fundamental conditions would independently break the case. First, Huntington slipping past Q4 2026 at the ~2026-10-21 print — that removes the contracted offset to the $19B Comerica exit and leaves organic flow standing alone. Second, total client net flows printing below the Q2 2026 level of $3.1B for a third consecutive quarter, which would say the 22% EPS growth is market beta, margin and buyback rather than a franchise gathering assets.

What would strengthen it: flows re-accelerating meaningfully above the $6.9B wrap level with Huntington live on the platform, alongside net investment income holding as the front end moves — at 11.18x forward that combination is not priced.

Correlation Notes

• Rate path. Net investment income on $25.5B of bank assets and $84B of client cash makes AMP a front-end proxy. It moves with SCHW, LPL, RJF and IBKR on deposit-beta, sweep-rate and cash-sorting headlines. New bank purchases were being struck at 5.2% as of 2026-07-23; that reinvestment yield is the number to track through any easing cycle.
• Equity beta. Asset-based fees on $1.81T of AUM/AUA are struck off market levels, so a material share of revenue tracks the S&P 500 with a reporting lag. Reported growth carries index beta independent of gathering.
• Advisor-recruiting cycle. AMP, LPL, RJF and Osaic compete for the same books. Package inflation — the eight-year paybacks management described on 2026-07-23 — compresses all of them together.
• Bank-channel M&A. The institutional business is a direct transmission line from regional bank consolidation. Comerica's move to Fifth Third took ~$18–19B out; Huntington's re-tender brought ~$28B in. Regional bank deal news moves AMP's institutional AUM in both directions and on short notice.